InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
4
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Greenway Schond L.. Officer active across 4 companies, notably Cerecor Inc.. In total, 13 filings have been recorded. Split: 4 buys · 4 sells. Total volume traded: €127k. History available since 10 June 2021. The latest transaction was disclosed on 25 March 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
5,560 shares@ US$9.7829.9% of flowCommon SharesSEC:0000950170-24-036578:0
5,652 shares@ US$3.6311.1% of flowCommon SharesSEC:0000950170-23-073063:0
1,908 shares@ US$3.576.5% of flowCommon SharesSEC:0000950170-23-049777:0
20,000 shares@ US$3.8041.9% of flowCommon SharesSEC:0000950170-23-044853:0
7,694 shares@ US$3.1913.3% of flowCommon SharesSEC:0000950170-23-030242:0
175,000 shares0Common SharesSEC:0001209191-23-025476:0
175,000 shares0Common SharesSEC:0001209191-23-019890:0
1,270,000 shares0Subordinate Voting SharesSEC:0001209191-22-033984:0
1,270,000 shares0Subordinate Voting SharesSEC:0001209191-22-031402:0
2,231 shares@ US$1.570.0009% mcap50.0% of flowCommon StockSEC:0001879785-21-000035:0
Ideal exit: 6 Sept 2022 (T+270)
2,231 shares@ US$1.5750.0% of flowCommon StockSEC:0001879785-21-000035
Ideal exit: 6 Sept 2022 (T+270)
652 shares@ US$2.68100.0% of flowCommon StockSEC:0001192482-21-000500
Ideal exit: 7 Mar 2022 (T+270)
652 shares@ US$2.68100.0% of flowCommon StockSEC:0001192482-21-000500:0
Ideal exit: 7 Mar 2022 (T+270)
13 of 13 declarations
About Greenway Schond L.
Greenway Schond L. is a director and insider at Cerecor Inc., Avalo Therapeutics, Inc., and Mind Medicine (MindMed) Inc.
